Medine.co.uk

Out of date information, search another

Salvian Capsules

Out of date information, search another
Informations for option: Salvian Capsules, show other option

SUMMARY OF PRODUCT CHARACTERISTICS

1 NAME OF THE MEDICINAL PRODUCT

SALVIAN Capsules

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Each capsule contains 300mg of Sage Leaf. (Salvia officinalis L.)

For list of excipients see section 6.1.

3 PHARMACEUTICAL FORM

Hard capsules.

Clear size 0 hard capsules.

4    CLINICAL PARTICULARS

4.1    Therapeutic indications

SALVIAN is a traditional herbal medicinal product used for the relief of excessive sweating associated with

the menopause, based on traditional use only.

4.2 Posology and method of administration

For oral short term use only.

Women experiencing menopausal symptoms:

For the temporary relief of excessive sweating associated with the menopause. Take 1 capsule per day

swallowed with water.

Duration of use: - 2 weeks.

If symptoms do not improve after 2 weeks during the use of SALVIAN a doctor or a qualified

healthcare care practitioner should be consulted.

There is no relevant use in children and adolescents under 18 years of age.

Contraindications

4.3


Patients with known hypersensitivity to Sage Leaf should not use SALVIAN.

4.4 Special warnings and precautions for use

There is no relevant use in children and adolescents under 18 years of age.

4.5 Interaction with other medicinal products and other forms of interaction

None reported

The intake of Sage preparations might influence the effect of medicinal products acting via GABA receptor

(e.g. barbiturates, benzodiazepines), even if not seen clinically. Therefore the concomitant use with such medicinal

products is not recommended.

4.6 Pregnancy and lactation

The safety of SALVIAN during pregnancy and lactation has not been established. Due to the lack of data,

use during pregnancy and lactation is not recommended.

4.7 Effects on ability to drive and use machines

SALVIAN may impair ability to drive and use machines.

Patients who are affected should not drive or operate machinery.

4.8 Undesirable effects

None Known.

If adverse reactions occur, a doctor or qualified health care practitioner should be consulted.

4.9 Overdose

Sage Leaf, at a dose in excess of 15g (equivalent to over 50 SALVIAN capsules), has been reported with a

sense of heat, tachycardia, vertigo and epileptic form convulsions.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Not required as per Article 16c(1)(a)(iii) of Directive 2001/83/EC as amended.

5.2 Pharmacokinetic properties

Not required as per Article 16c(1)(a)(iii) of Directive 2001/83/EC as amended.

5.3 Preclinical safety data

Test on reproductive toxicity, genotoxicity and carcinogenicity have not been performed.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Hypromellose (capsule shell)

6.2 Incompatibilities

Not Applicable.

6.3


Shelf life

3 years.

6.4 Special precautions for storage

Store below 25°C in the original package.

6.5 Nature and contents of container

Duma 110ml HDPE plastic container and tamper evident threaded Duma cap. SALVIAN pack contains 30 or 60 Capsules.

6.6 Special precautions for disposal

There are no special precautions for disposal of SALVIAN capsules. When the container is empty the label should

be removed and the container placed in a recycling bin.

7 MARKETING AUTHORISATION HOLDER

Bio-Health Limited Culpeper Close Medway City Estate Rochester Kent

ME2 4HU

8    MARKETING AUTHORISATION NUMBER(S)

THR 15817/0005

9    DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

03/09/2009

10    DATE OF REVISION OF THE TEXT

03/09/2009